Annual Current Liabilities
$158.80 M
+$136.82 M+622.72%
December 31, 2023
Summary
- As of February 7, 2025, TRDA annual total current liabilities is $158.80 million, with the most recent change of +$136.82 million (+622.72%) on December 31, 2023.
- During the last 3 years, TRDA annual current liabilities has risen by +$155.44 million (+4627.48%).
- TRDA annual current liabilities is now at all-time high.
Performance
TRDA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$70.60 M
-$15.21 M-17.72%
September 30, 2024
Summary
- As of February 7, 2025, TRDA quarterly total current liabilities is $70.60 million, with the most recent change of -$15.21 million (-17.72%) on September 30, 2024.
- Over the past year, TRDA quarterly current liabilities has dropped by -$94.83 million (-57.32%).
- TRDA quarterly current liabilities is now -59.41% below its all-time high of $173.94 million, reached on March 31, 2024.
Performance
TRDA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
TRDA Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +622.7% | -57.3% |
| 3 y3 years | +4627.5% | +221.3% |
| 5 y5 years | +8166.3% | +221.3% |
TRDA Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2263.4% | -59.4% | +950.8% |
| 5 y | 5-year | at high | +8166.3% | -59.4% | +2001.9% |
| alltime | all time | at high | +8166.3% | -59.4% | +2001.9% |
Entrada Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $70.60 M(-17.7%) |
| Jun 2024 | - | $85.81 M(-50.7%) |
| Mar 2024 | - | $173.94 M(+9.5%) |
| Dec 2023 | $158.80 M(+622.7%) | $158.80 M(-4.0%) |
| Sep 2023 | - | $165.43 M(+31.4%) |
| Jun 2023 | - | $125.94 M(-14.7%) |
| Mar 2023 | - | $147.59 M(+571.7%) |
| Dec 2022 | $21.97 M | $21.97 M(+2.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $21.55 M(+19.2%) |
| Jun 2022 | - | $18.08 M(+17.2%) |
| Mar 2022 | - | $15.43 M(+129.6%) |
| Dec 2021 | $6.72 M(+100.0%) | $6.72 M(-6.1%) |
| Sep 2021 | - | $7.16 M(+57.8%) |
| Jun 2021 | - | $4.54 M(+35.0%) |
| Dec 2020 | $3.36 M(+74.9%) | $3.36 M |
| Dec 2019 | $1.92 M | - |
FAQ
- What is Entrada Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Entrada Therapeutics?
- What is Entrada Therapeutics annual current liabilities year-on-year change?
- What is Entrada Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Entrada Therapeutics?
- What is Entrada Therapeutics quarterly current liabilities year-on-year change?
What is Entrada Therapeutics annual total current liabilities?
The current annual current liabilities of TRDA is $158.80 M
What is the all time high annual current liabilities for Entrada Therapeutics?
Entrada Therapeutics all-time high annual total current liabilities is $158.80 M
What is Entrada Therapeutics annual current liabilities year-on-year change?
Over the past year, TRDA annual total current liabilities has changed by +$136.82 M (+622.72%)
What is Entrada Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of TRDA is $70.60 M
What is the all time high quarterly current liabilities for Entrada Therapeutics?
Entrada Therapeutics all-time high quarterly total current liabilities is $173.94 M
What is Entrada Therapeutics quarterly current liabilities year-on-year change?
Over the past year, TRDA quarterly total current liabilities has changed by -$94.83 M (-57.32%)